Adverse Effects of Amiodarone
- 10 Downloads
Amiodarone is an extremely effective antiarrhythmic agent for the treatment of both life-threatening ventricular arrhythmias and refractory supraventricular tachyarrhythmias. Subjective minor side effects are common with amiodarone but rarely require discontinuation of therapy and are often handled by dose reduction. Serious end-organ toxicity, including pulmonry fibrosis and drug-induced hepatitis, have been the most common indications for discontinuing amiodarone therapy in these patients.
KeywordsAmiodarone Flecainide Pulmonary Toxicity American Heart Journal Amiodarone Therapy
Unable to display preview. Download preview PDF.
- Burger A, Dinichett C, Nicod P, Jenny N, LeMarchand BP, et al. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin and thyrotropin: a drug influencing peripheral metabolism of thyroid hormones. Journal of Clinical Investigation 58: 255–259, 1976PubMedCrossRefGoogle Scholar
- Heger JJ, Prystowsky EN, Miles WM, Zipes DP. Clinical use and pharmacology of amiodarone. Medical Clinics of America 68: 1339–1366, 1984Google Scholar
- Nademanee K, Kannan R, Hendrickson J, Ookhtens M, Kay I, et al. Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications. Journal of the American College of Cardiology 4: 111–116, 1984PubMedCrossRefGoogle Scholar
- Nademanee K, Singh BN, Hendrickson JA, Reed AW, Melmed S. et al. Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy. Circulation 62: 202–221, 1982Google Scholar
- Rinkenberger RL, Prystowsky EN, Jackman WM, Naccarelli GV, Heger JJ, et al. Drug conversion of nonsustained to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms. American Heart Journal 103: 177–184, 1982PubMedCrossRefGoogle Scholar
- Soussi A, Colonna D. Troubles du rythme auriculaire et amiodarone. Journal des Agreges 7: 43, 1974Google Scholar
- Van Roojj WJ, Van der Meer SC, Van Rayen EA, Van Zandwijk N, Darmanata JI. Pulmonary gallium-67 uptake in amiodarone pneumonitis. Journal of Nuclear Medicine 25: 211–213, 1984Google Scholar
- Wilson FM, Schmitt TE, Grayson M. Amiodarone-induced cornea verticillata. Annals of Ophthalmology 12: 657–660, 1980Google Scholar